218 related articles for article (PubMed ID: 30946964)
1. Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
O'Driscoll CM; Bernkop-Schnürch A; Friedl JD; Préat V; Jannin V
Eur J Pharm Sci; 2019 May; 133():190-204. PubMed ID: 30946964
[TBL] [Abstract][Full Text] [Related]
2. Oral nucleic acid therapy using multicompartmental delivery systems.
Attarwala H; Han M; Kim J; Amiji M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
[TBL] [Abstract][Full Text] [Related]
3. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
Fattal E; Fay F
Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
[TBL] [Abstract][Full Text] [Related]
6. Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.
Kumari N; Siddhanta K; Panja S; Joshi V; Jogdeo C; Kapoor E; Khan R; Kollala SS; Kumar B; Sil D; Singh AB; Murry DJ; Oupický D
Pharm Res; 2023 Jan; 40(1):107-122. PubMed ID: 36271204
[TBL] [Abstract][Full Text] [Related]
7. Smart polymeric nanocarriers for small nucleic acid delivery.
Miyata K
Drug Discov Ther; 2016 Nov; 10(5):236-247. PubMed ID: 27746418
[TBL] [Abstract][Full Text] [Related]
8. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
[TBL] [Abstract][Full Text] [Related]
9. Peptides for nucleic acid delivery.
Lehto T; Ezzat K; Wood MJA; El Andaloussi S
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
[TBL] [Abstract][Full Text] [Related]
11. Liposomal delivery of nucleic acids in vivo.
Smyth Templeton N
DNA Cell Biol; 2002 Dec; 21(12):857-67. PubMed ID: 12573046
[TBL] [Abstract][Full Text] [Related]
12. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
Kozielski KL; Rui Y; Green JJ
Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
[TBL] [Abstract][Full Text] [Related]
13. Non-viral nucleic acid delivery: key challenges and future directions.
Elsabahy M; Nazarali A; Foldvari M
Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route.
Chen F; Liu Q; Xiong Y; Xu L
Front Pharmacol; 2022; 13():984981. PubMed ID: 36105233
[TBL] [Abstract][Full Text] [Related]
15. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
Colombo S; Zeng X; Ragelle H; Foged C
Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
[TBL] [Abstract][Full Text] [Related]
16. Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery.
Hu M; Li X; You Z; Cai R; Chen C
Adv Mater; 2024 May; 36(22):e2303266. PubMed ID: 37792475
[TBL] [Abstract][Full Text] [Related]
17. Nucleic Acid-Based Therapeutics for Pulmonary Diseases.
Chen J; Tang Y; Liu Y; Dou Y
AAPS PharmSciTech; 2018 Nov; 19(8):3670-3680. PubMed ID: 30338490
[TBL] [Abstract][Full Text] [Related]
18. Impact of chemistry and nanoformulation parameters on cellular uptake and airway distribution of RNA oligonucleotides.
Oude Blenke E; Mahakena S; Fens M; van den Dikkenberg J; Holkers M; Mastrobattista E
J Control Release; 2020 Jan; 317():154-165. PubMed ID: 31765703
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of nucleic acid-based therapeutics.
Hardee GE
Ther Deliv; 2012 Feb; 3(2):143-5. PubMed ID: 22834192
[No Abstract] [Full Text] [Related]
20. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
